Pillstats
Rx only · Cream · Topical

Fluocinonide

Brands: Vanos · Fluocinonide

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC05AA11
RxCUI (US)4462
US makers14 labelers
Packages59
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 33 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.150$0.299$0.449$0.598Dec 2025Mar 2026Jul 2026
$0.436
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
13
Active US suppliers
29%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

11K22K34K45K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
1.8M
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown10SUPPLYING
Cosette Pharmaceuticals, Inc.unknown6SUPPLYING
Bryant Ranch Prepackrepackager6SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown6SUPPLYING
Encube Ethicals, Inc.unknown4SUPPLYING
A-S Medication Solutionsunknown4SUPPLYING
Amneal Pharmaceuticals LLCunknown4SUPPLYING
Asclemed USA, Inc.unknown3SUPPLYING
Zydus Lifesciences Limitedunknown3SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown3SUPPLYING
Viona Pharmaceuticals Incunknown3SUPPLYING
NuCare Pharmaceuticals, Inc.unknown3SUPPLYING
Preferred Pharmaceuticals Inc.unknown1SUPPLYING
Bausch Health US, LLCunknown3EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 25, 2026
    RECALLRecall (Class II): Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1…

    Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.

  • Mar 25, 2026
    RECALLRecall (Class II): Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1…

    Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.

  • Mar 25, 2026
    RECALLRecall (Class II): Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1…

    Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA.

  • Sep 20, 2017
    RECALLRecall (Class III): Fluocinonide Gel USP, 0.05%, 15 g tube, Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton Ontario Canada L6T1C1, Di…

    Cross contamination with other products: traces of Dapsone were found in the finished product. — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — Nationwide

  • Mar 17, 2017
    RECALLRecall (Class III): Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Br…

    Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate. — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — U.S. Nationwide